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Background: The self-reported health and functional status of persons with back pain in the United States have
declined in recent years, despite greatly increased medical expenditures due to this problem. Although patient
psychosocial factors such as pain-related beliefs, thoughts and coping behaviors have been demonstrated to affect
how well patients respond to treatments for back pain, few patients receive treatments that address these factors.
Cognitive-behavioral therapy (CBT), which addresses psychosocial factors, has been found to be effective for
back pain, but access to qualified therapists is limited. Another treatment option with potential for addressing
psychosocial issues, mindfulness-based stress reduction (MBSR), is increasingly available. MBSR has been found to be
helpful for various mental and physical conditions, but it has not been well-studied for application with chronic
back pain patients. In this trial, we will seek to determine whether MBSR is an effective and cost-effective treatment
option for persons with chronic back pain, compare its effectiveness and cost-effectiveness compared with CBT and
explore the psychosocial variables that may mediate the effects of MBSR and CBT on patient outcomes.
Methods/Design: In this trial, we will randomize 397 adults with nonspecific chronic back pain to CBT, MBSR or
usual care arms (99 per group). Both interventions will consist of eight weekly 2-hour group sessions supplemented
by home practice. The MBSR protocol also includes an optional 6-hour retreat. Interviewers masked to treatment
assignments will assess outcomes 5, 10, 26 and 52 weeks postrandomization. The primary outcomes will be
pain-related functional limitations (based on the Roland Disability Questionnaire) and symptom bothersomeness
(rated on a 0 to 10 numerical rating scale) at 26 weeks.
Discussion: If MBSR is found to be an effective and cost-effective treatment option for patients with chronic back
pain, it will become a valuable addition to the limited treatment options available to patients with significant
psychosocial contributors to their pain.
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Identifying cost-effective treatments for chronic low back
pain (CLBP) remains a challenge for clinicians, researchers,
payers and patients. About $26 billion is spent annually in
the United States in direct costs of medical care for back
pain [1]. In 2002, the estimated costs of lost worker prod-
uctivity due to back pain were $19.8 billion [2]. Despite nu-
merous options for evaluating and treating back pain, as
well as the greatly increased medical care resources de-
voted to this problem, the health and functional status of
persons with back pain in the United States has deterio-
rated [3]. Furthermore, both providers and patients are dis-
satisfied with the status quo [4-6] and continue to search
for better treatment options.
There is substantial evidence that patient psychosocial
factors, such as pain-related beliefs, thoughts and coping
behaviors, can have a significant impact on the experience
of pain and its effects on functioning [7]. This evidence
highlights the potential value of treatments for back pain
that address both the mind and the body. In fact, four of
the eight nonpharmacologic treatments recommended by
the American College of Physicians and the American
Pain Society guidelines for persistent back pain include
“mind–body” components [8]. One of these treatments,
cognitive-behavioral therapy (CBT), includes mind–body
components such as relaxation training and has been
found to be effective for a variety of chronic pain prob-
lems, including back pain [9-13]. CBT has become the
most widely applied psychosocial treatment for patients
with chronic back pain. Another mind–body therapy,
mindfulness-based stress reduction (MBSR) [14,15], fo-
cuses on teaching techniques to increase mindfulness.
MBSR and related mindfulness-based interventions have
been found to be helpful for a broad range of mental and
physical health conditions, including chronic pain [14-19],
but they have not been well-studied for chronic back pain
[20-24]. Only a few small pilot trials have evaluated the ef-
fectiveness of MBSR for back pain [25,26] and all reported
improvements in pain intensity [27] or patients’ accept-
ance of pain [28,29].
Further research on the comparative effectiveness and
cost-effectiveness of mind–body therapies should be a
priority in back pain research for the following reasons:
(1) the large personal and societal impact of chronic
back pain, (2) the modest effectiveness of current treat-
ments, (3) the positive results of the few trials in which
researchers have evaluated mind–body therapies for back
pain and (4) the growing popularity and safety, as well as
the relatively low cost, of mind–body therapies. To help
fill this knowledge gap, we are conducting a randomized
trial to evaluate the effectiveness, comparative effective-
ness and cost-effectiveness of MBSR and group CBT,
compared with usual medical care only, for patients with
chronic back pain.Specific aims
Our specific aims and their corresponding hypotheses
are outlined below.
1. To determine whether MBSR is an effective adjunct
to usual medical care for persons with CLBP
Hypothesis 1: Individuals randomized to the MBSR
course will show greater short-term (8 and
26 weeks) and long-term (52 weeks) improvement
in pain-related activity limitations, pain
bothersomeness and other health-related
outcomes than those randomized to continued
usual care alone.
2. To compare the effectiveness of MBSR and group
CBT in decreasing back pain–related activity
limitations and pain bothersomeness
Hypothesis 2: MBSR will be more effective than
group CBT in decreasing pain-related activity
limitations and pain bothersomeness in both the
short term and long term. The rationale for this
hypothesis is based on (1) the modest effectiveness
of CBT for chronic back pain found in past
studies, (2) the positive results of the limited initial
research evaluating MBSR for chronic back pain
and (3) growing evidence that an integral part of
MBSR training (but not CBT training)—yoga—is
effective for chronic back pain.
3. To identify the mediators of any observed effects of
MBSR and group CBT on pain-related activity
limitations and pain bothersomeness
Hypothesis 3a: The effects of MBSR on activity
limitations and pain bothersomeness will be
mediated by increases in mindfulness and
acceptance of pain.
Hypothesis 3b: The effects of CBT on activity
limitations and pain bothersomeness will be
mediated by changes in pain-related cognition
(decreases in catastrophizing, beliefs that one is
disabled by pain and beliefs that pain signals harm,
as well as increases in perceived control over pain
and self-efficacy for managing pain) and changes
in coping behaviors (increased use of relaxation,
task persistence and coping self-statements and
decreased use of rest).
4. To compare the cost-effectiveness of MBSR and
group CBT as adjuncts to usual care for persons
with chronic back pain
Hypothesis 4: Both MBSR and group CBT will be
cost-effective adjuncts to usual care.
We will also explore whether certain patient characteris-
tics predict or moderate treatment effects. For example,
we will explore whether patients with higher levels of de-
pression are less likely to improve with both CBT and
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from CBT than from MBSR (that is, whether depression
level is a moderator of treatment effects).
Methods/Design
Overview
We are conducting a randomized clinical trial in which in-
dividuals with CLBP are randomly assigned to group CBT,
a group MBSR course or usual care alone (Figure 1). Par-
ticipants will be followed for 52 weeks after randomization.
Telephone interviewers masked to participants’ treatment
assignments will assess outcomes 4, 8, 26 and 52 weeks
postrandomization. The primary outcomes we will assess
are pain-related activity limitations and pain bother-
someness. Participants will be informed that the study
researchers are comparing “two different widely used
pain self-management programs that have been found
helpful for reducing pain and making it easier to carry
out daily activities”.
The protocol for this trial has been approved by the
Human Subjects Review Committee of the Group Health
Cooperative (250681-22). All participants will be required
to give their informed consent before enrollment in this
study.
Study sample and setting
The primary source of participants for this trial will be
the Group Health Cooperative (GHC), a group-model,





8 classes over 8 weeks
Questionnaire assessment of outc





Figure 1 Flowchart of the trial protocol. CBT, Cognitive-behavioral thera600,000 enrollees through its own primary care facilities
in Washington state. As needed to achieve recruitment
goals, direct mailings will be sent to persons 20 to 70 years
of age living in the areas served by the GHC.
Inclusion and exclusion criteria
We are recruiting individuals from 20 to 70 years of age
whose back pain has persisted for at least 3 months. The in-
clusion and exclusion criteria were developed to maximize
the enrollment of appropriate patients while screening out
patients who have low back pain of a specific nature (for
example, spinal stenosis) or a complicated nature or who
would have difficulty completing the study measures or
interventions (for example, psychosis). Reasons for ex-
clusion of GHC members were identified on the basis of
(1) automated data recorded (using the International
Classification of Diseases, Ninth Revision coding sys-
tem), during all visits over the course of the previous
year and (2) eligibility interviews conducted by telephone.
For non-GHC members, reasons for exclusion were iden-
tified on the basis of telephone interviews. Tables 1 and 2
list the inclusion and exclusion criteria, respectively, as
well as the rationale for each criterion and the informa-
tion sources.
In addition, we require that participants be willing and
able to attend the CBT or MBSR classes during the 8-week
intervention period if assigned to one of those treatments,
and to respond to the four follow-up questionnaires so that






omes at 4, 8, 26 and 52 weeks
py; MBSR, Mindfulness-based stress reduction.
Table 1 Inclusion criteria
Inclusion criteria Rationales Sources
Primary sources A, TI
All GHC members with at least one primary care visit for
back pain within the previous 3 to 15 months
Initial targeting of members with back pain visits in recent
past is an efficient method of identifying persons with
chronic back pain.
Random sample of GHC members without visits for
back pain within the previous 3 to 15 months
Emphasis placed on recruitment of GHC members to obtain
complete treatment utilization and cost data from GHC
medical records
GHC members responding to an ad in the GHC magazine
Secondary sources A, TI
Random samples of nonmembers of GHC living in
Washington state
Nonmembers of GHC included to ensure that recruitment
goals are met.
Age range 20 to 70 years Chronic back pain in children is a result of causes different
from those we will study.
Adults have a higher risk of undiagnosed serious conditions
that cause back pain.
Nonspecific, uncomplicated back pain as defined by ICD-9 codes
(for primary source only: GHC members with primary care visits
for back pain in the previous 3 to 15 months)





724.8 Other symptoms referable to back
846.0-9 Sprains and strains, sacroiliac
847.2 Sprains and strains, lumbar
847.3 Sprains and strains, sacral
847.9 Sprains and strains, unspecified site of the back
GHC, Group Health Cooperative; ICD-9, International Classification of Diseases, Ninth Revision. A, Automated data gathered from visits; TI, Telephone interview.
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Because the study intervention involves classes, we are
recruiting participants in ten cohorts consisting of up to
forty-five individuals each. We are recruiting participants
from three main sources: (1) GHC members who have
made visits to their primary care providers for low back
pain and whose pain has persisted for at least 3 months,
(2) GHC members who have not made a visit to their
primary care provider for back pain but who are be-
tween the ages of 20 and 70 years and who respond to
our nontargeted GHC mailing or our ad in GHC’s twice-
yearly magazine and (3) community residents between
the ages of 20 and 70 years who respond to a direct mail
recruitment postcard.
For the targeted GHC population, a programmer will
use GHC’s administrative and clinical electronic data-
bases to identify potentially eligible members with a visit
in the previous 3 to 15 months to a provider that re-
sulted in a diagnosis consistent with nonspecific low
back pain. These GHC members are mailed a letter and
consent checklist that explains the study and eligibility
requirements. Members interested in participating sign
and return a statement indicating their willingness to be
contacted. A research specialist then calls the potential
participant to ask questions; determine eligibility; clarifyrisks, benefits and expected commitment to the study;
and request informed consent. After informed consent
has been obtained from the individual, the baseline tele-
phone assessment is conducted.
For the nontargeted GHC population (that is, GHC
members without visits with back pain diagnoses received
within the previous 3 to 15 months but who could pos-
sibly have low back pain), a programmer uses administra-
tive and clinical electronic databases to identify potentially
eligible members who were not included in the targeted
sample described in the preceding paragraph. This popu-
lation also includes GHC members who respond to an ad
in the GHC magazine. The same methods used for the
targeted population are then used to contact and screen
the potential participants, obtain their informed consent
and collect baseline data.
With regard to community residents, we have pur-
chased lists of the names and addresses of a randomly
selected sample of people living within our recruitment
area who are between 20 and 70 years of age. The people
on the list are sent direct mail postcards describing the
study including information regarding how to contact
study staff if interested in participating. Once an inter-
ested person has contacted the research team the same
process detailed above is followed.
Table 2 Exclusion criteriaa
Exclusion criteria Rationales Sources
Patient claims visit was not for low back pain Study restricted to low back pain TI
Low back pain has lasted <3 months Low back pain not chronic TI
Self-rated bothersomeness of pain rating of <4 (on 0 to 10 scale)
and pain interference with activities rating <3 (on 0 to 10 scale)
during previous week
Back pain too mild to detect improvement TI
Abdominal aneurysm Back pain due to or possibly result of specific disease
or condition
A
Cancer in previous 5 years, other than basal cell or squamous
cell cancer of the skin
A, TI
Discitis A
Degenerative disc disease A
Fracture of vertebra A, TI
Infectious cause of back pain TI
Pregnancy TI
Scoliosis, severe or progressive A, TI
Spinal stenosis A, TI
Spondylolisthesis A, TI
Back surgery within previous 2 years Back problem is complicated by medical or medicolegal
issues
TI
Seeking or receiving compensation for back pain or involved in
litigation related to back pain




No way to play home practice audio recordings at home TI
Paralysis A
Psychoses, major A, TI
Schedules do not permit participation in classes or home practice
(including planning to move out of town)
TI
Vision problems, severe TI
Hearing problems, severe TI
Lack of transportation TI
Fibromyalgia Condition or circumstance might confound treatment
effects or interpretation of data
TI
Rheumatoid arthritis and/or anklyosing spondylitis A, TI
Other disabling chronic conditions (for example, disabling heart or
lung disease, diabetic neuropathy, receiving treatment for hepatitis)
TI
Planning on seeing a specialist for back pain (for example, surgeon,
neurologist, rheumatologist)
TI
Dementia Condition would make it difficult to provide fully
informed consent
A
Unable to read or speak English TI
Currently taking a mind–body class for back pain or class taken
within previous 1 year
Possible bias due to current or recent interventions TI
aA, Automated data gathered from visits; TI, Telephone interview.
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remain eligible at the time the classes begin, those who
consent more than 14 days prior to the start of the inter-
vention classes will be recontacted approximately 0 to14 days prior to the first class to reconfirm their eligibility.
The primary concern is to exclude persons who no longer
have at least moderate baseline ratings of pain bother-
someness and pain-related interference with activities.
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final informed consent will be administered the baseline
questionnaire.Randomization
After completing the baseline assessment, participants
will be randomized in equal proportions to the MBSR,
CBT or usual care group. Those randomized to the
MBSR or CBT group will not be informed of their type
of treatment until they arrive at the first classes, which
will occur simultaneously in the same building. The
intervention group will be assigned on the basis of a
computer-generated sequence of random numbers using a
program which ensures that allocation cannot be changed
after randomization. To ensure balance on a key baseline
prognostic factor, randomization will be stratified based
on our primary outcome measurement instrument: the
modified version of the Roland Disability Questionnaire
(RDQ) [30,31]. We will stratify participants into two ac-
tivity limitations groups: moderate (RDQ score ≤12 on a
0 to 23 scale) and high (RDQ scores ≥13). Participants
will be randomized within these strata in blocks of
varying size (three, six or nine) to ensure a balanced but
unpredictable assignment of participants. During re-
cruitment, the study biostatistician will receive aggre-
gated counts of participants randomized to each groupTable 3 Content of cognitive-behavioral therapy and mindful
Session CBT
1 Rationale and evidence base for CBT, pain neurobiology,
overview of skills, rationale for relaxation training, diaphragmati
breathing instruction, introduction to behavioral goal setting
(physical activity and home practice)
2 Behavioral goal setting, physical activity and pacing activity,
pleasant event scheduling, pain flare-up plan, diaphragmatic
breathing and seven-muscle-group progressive muscle relaxatio
(PMR) instruction
3 Role of thoughts and feelings in pain, introduction to the CBT
model, thought-monitoring record, diaphragmatic and
four-muscle-group PMR instruction, setting and working toward
behavioral goals
4 Challenging automatic thoughts related to pain, setting and
working toward behavioral goals, diaphragmatic breathing and
four-muscle-group/no-tension PMR instruction
5 Challenging automatic thoughts and generating alternate
thoughts, distraction techniques, brief body scan relaxation
instruction, setting and working toward behavioral goals
6 Alternate thoughts, thought stopping, behavioral activation,
mini-relaxation instruction, setting and working toward behav-
ioral goals
7 Rehearsing pain coping skills, identifying and challenging
negative thoughts, setting and working toward behavioral goa
mini-relaxation instruction, sleep tips
8 Maintenance of coping skills, relapse prevention, personal plan
for the future
aCBT, Cognitive-behavioral therapy; MBSR, Mindfulness-based stress reduction.to assure that the preprogrammed randomization algo-
rithm is functioning properly.
Study treatments
Both the group CBT and MBSR class series consist of
eight weekly 2-hour sessions supplemented by home
activities.
Mindfulness-based stress reduction
Mindfulness-based stress reduction, a 30-year-old treat-
ment program developed by Jon Kabat-Zinn, is well-
described in the literature [32-34]. The authors of a recent
meta-analysis found that MBSR had moderate effect sizes
for improving the physical and mental well-being of pa-
tients with a variety of health conditions [16]. Our MBSR
program is closely modeled on the original one and in-
cludes eight weekly 2-hour classes (summarized in Table 3),
a 6-hour retreat between weeks 6 and 7 and up to 45 mi-
nutes per day of home practice. Our MBSR protocol was
adapted by a senior MBSR instructor from the 2009 MBSR
instructor’s manual used at the University of Massachusetts
[35]. This manual permits latitude in how instructors
introduce mindfulness and its practice to participants. The
handouts and home practice materials are standardized for
this study.
Participants will be given a packet of information dur-
ing the first class that includes a course outline andness-based stress reduction class sessionsa
MBSR
c
Setting expectations, defining mindfulness, engaging in
mindfulness exercise and movement, abdominal breathing
instructions, introducing home practice
n
Perception and responding creatively to perceptions, engaging
in yoga, body scan, discussion of developing a practice
Pleasure and power of being present, engaging in yoga, walking
meditation, discussing how to bring more pleasant events into
our lives
Getting unstuck from old patterns, engaging in yoga and/or
movement, sitting meditation, stress (define and identify how
and why we stay stuck), dealing with pain
Reacting and responding differently to stress, engaging in yoga,
participating in guided meditation, establishing coping strategies
(living with difficulties)
Learning about communication patterns, engaging in yoga
and/or meditation, styles of communicating with others
(effective and ineffective)
ls,
Integrating learning from techniques, yoga and/or meditation,
practical ways to bring mindfulness into daily life
This is the rest of your life, review mindfulness techniques and
applications, closure
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fulness, meditation, communication skills and effects of
stress on the body, emotions and behavior; homework
assignments; poems; and a bibliography. All sessions will
include mindfulness exercises, and all but the first will
include yoga or other forms of mindful movement.
Participants will be given audio recordings of the mind-
fulness and yoga techniques, which will have been re-
corded by their own instructors. Participants will be
asked to practice the techniques discussed in each class
daily for up to 45 minutes throughout the intervention
period and after classes end. They will also be assigned
readings to complete before each class. Time will be
devoted in each class to a review of challenges that par-
ticipants have had in practicing what they learned in
previous classes and with their homework. An optional
day of practice on the Saturday between the sixth and
seventh classes will be offered. This 6-hour “retreat” will
be held with the participants in silence and only the in-
structor speaking. This will provide participants an op-
portunity to deepen what they have learned in class.Cognitive-behavioral therapy
CBT for chronic pain is well-described in the literature
and has been found to be modestly to moderately effect-
ive in improving chronic pain problems [9-13]. There is
no single, standardized CBT intervention for chronic pain,
although all CBT interventions are based on the assump-
tion that both cognition and behavior influence adaptation
to chronic pain and that maladaptive cognition and behav-
ior can be identified and changed to improve patient func-
tioning [36]. CBT emphasizes active, structured techniques
to teach patients how to identify, monitor and change mal-
adaptive thoughts, feelings and behaviors, with a focus on
helping patients to acquire skills that they can apply to a
variety of problems and collaboration between the pa-
tient and therapist. A variety of techniques are taught,
including training in pain coping skills (for example, use
of positive coping self-statements, distraction, relax-
ation and problem-solving). CBT also promotes setting
and working toward behavioral goals.
Both individual and group formats have been used in
CBT. Group CBT is often an important component of
multidisciplinary pain treatment programs. We will use
a group CBT format because it has been found to be effi-
cacious [37-40], is more resource-efficient than individual
therapy and provides patients with the potential benefits
deriving from contact with, and support and encourage-
ment from, others with similar experiences and problems.
In addition, using group formats for both MBSR and
CBT will eliminate intervention format as a possible ex-
planation for any differences observed between the two
therapies.For this study, we developed a detailed therapist’s man-
ual with content specific for each session, as well as a par-
ticipant’s workbook containing materials for use in each
session. We developed the therapist’s manual and partici-
pant’s workbooks based on existing published resources as
well as on materials we have used in prior studies [39-47].
The CBT intervention (Table 3) will consist of eight
weekly 2-hour sessions that will provide (1) education
about the role of maladaptive automatic thoughts (for
example, catastrophizing) and beliefs (for example, one’s
ability to control pain, hurt equals harm) common in
people with depression, anxiety and/or chronic pain and
(2) instruction and practice in identifying and challen-
ging negative thoughts, the use of thought-stopping
techniques, the use of positive coping self-statements
and goal-setting, relaxation techniques and coping with
pain flare-ups. The intervention will also include educa-
tion about activity pacing and scheduling and about re-
lapse prevention and maintenance of gains. Participants
will be given audio recordings of relaxation and imagery
exercises and asked to set goals regarding their relax-
ation practice. During each session, participants will
complete a personal action plan for activities to be com-
pleted between sessions. These plans will be used as logs
for setting specific home practice goals and checking off
activities completed during the week to be reviewed at
the next week’s session.Usual care
The usual care group will receive whatever medical care
they would normally receive during the study period. To
minimize possible disappointment with not being ran-
domized to a mind–body treatment, participants in this
group will receive $50 compensation.Class sites
The CBT and MBSR classes will be held in facilities close
to concentrations of GHC members in Washington state
(Bellevue, Bellingham, Olympia, Seattle, Spokane and
Tacoma).Instructors
All MBSR instructors will have received either formal
training in teaching MBSR from the Center for Mindful-
ness at the University of Massachusetts or equivalent
training. They will themselves be practitioners of both
mindfulness and a body-oriented discipline (for example,
yoga), will have taught MBSR previously and will have
made mindfulness a core component of their lives. The
CBT intervention will be conducted by doctorate-level
clinical psychologists with previous experience in pro-
viding CBT to patients with chronic pain.
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All CBT instructors will be trained in the study protocol
for the CBT intervention by the study’s clinical psych-
ologist investigators (BHB and JAT), who are very expe-
rienced in administering CBT to patients with chronic
pain. BHB will supervise the CBT instructors. One of the
investigators (KJS) will train the MBSR instructors in the
adapted MBSR protocol and supervise them. Each in-
structor will attend weekly supervision sessions, which will
include discussion of positive experiences, adverse events,
concerns raised by the instructor or participants and
protocol fidelity. Treatment fidelity checklists highlighting
the essential components for each session were created
for both the CBT and MBSR arms. A trained research spe-
cialist will use the fidelity checklist during live observation
of every session. The research specialist will provide feed-
back to the supervisor to facilitate weekly supervision of
the instructors. In addition, all sessions will be audio-
recorded. The supervisors will listen to a random sample
and requested portions of sessions and will monitor them
using the fidelity checklist. Feedback will be provided to
the instructors during their weekly supervision sessions.
Treatment fidelity will be monitored in both intervention
groups by KJS and BHB with assistance from research spe-
cialists. In addition, they will review and rate on the fidel-
ity checklist a random sample of the recorded sessions.Participant retention and adherence to home practice
Participants will receive a reminder call before the first
class and whenever they miss a class. They will be asked
to record their daily home practice on weekly logs. Ques-
tions about their home practice during the prior week will
also be included in all follow-up interviews. To maintain
interviewer blinding, adherence questions will be asked
after all outcome data have been recorded.Measures
We will assess a variety of participant baseline character-
istics, including sociodemographic characteristics, back
pain history and expectations of the helpfulness of the
mind–body treatments for back pain (Table 4).
We will assess a core set of outcomes for patients with
spinal disorders (back-related function, pain, general health
status, work disability and patient satisfaction) [48] that are
consistent with the Initiative on Methods, Measurement,
and Pain Assessment in Clinical Trials recommendations
for clinical trials of chronic pain treatment efficacy and
effectiveness [49]. We will measure both short-term
outcomes (8 and 26 weeks) and long-term outcomes
(52 weeks). We will also include a brief, 4-week, mid-
treatment assessment to permit analyses of the hypo-
thesized mediators of the effects of MBSR and CBT on
the primary outcomes. The primary study endpoint is26 weeks. Participants will be paid $20 for each follow-
up interview completed to maximize response rates.
Co–primary outcome measures
The co–primary outcome measures will be back-related
activity limitations and back pain bothersomeness.
Back-related activity limitations will be measured with
the modified RDQ, which asks whether 23 specific activ-
ities have been limited due to back pain (yes or no) [30].
We have further modified the RDQ to ask a question
about the previous week rather than just “today”. The ori-
ginal RDQ has been found to be reliable, valid and sensi-
tive to clinical changes [31,48,50-53], and it is appropriate
for telephone administration and use with patients with
moderate activity limitations [50].
Back pain bothersomeness will be measured by asking
participants to rate how bothersome their back pain has
been during the previous week on a 0 to 10 scale (0 = “not
at all bothersome” and 10 = “extremely bothersome”). On
the basis of data compiled from a similar group of GHC
members with back pain, we found this bothersomeness
measure to be highly correlated with a 0 to 10 measure of
pain intensity (r = 0.8 to 0.9; unpublished data (DCC and
KJS) and with measures of function and other outcome
measures [54]. The validity of numerical rating scales of
pain has been well-documented, and such scales have
demonstrated sensitivity in detecting changes in pain after
treatment [55].
We will analyze and report these co–primary outcomes
in two ways. First, for our primary endpoint analyses, we
will compare the percentages of participants in the three
treatment groups who achieve clinically meaningful im-
provement (≥30% improvement from baseline) [56,57] at
each time point (with 26-week follow-up being the pri-
mary endpoint). We will then examine, in a secondary
outcome analysis, the adjusted mean differences between
groups on these measures at the time of follow-up.
Secondary outcome measures
The secondary outcomes that we will measure are depres-
sive symptoms, anxiety, pain-related activity interference,
global improvement with treatment, use of medications for
back pain, general health status and qualitative outcomes.
Depressive symptoms will be assessed with the Patient
Health Questionnaire-8 (PHQ-8) [58]. With the excep-
tion of the elimination of a question about suicidal
ideation, the PHQ-8 is identical to the PHQ-9, which
has been found to be reliable, valid and responsive to
change [59,60].
Anxiety will be measured with the 2-item General-
ized Anxiety Disorder scale (GAD-2), which has dem-
onstrated high sensitivity and specificity in detecting
generalized anxiety disorder in primary care popula-
tions [61,62].
Table 4 Baseline and follow-up measuresa
Measures Baseline 4 wk 8 wk 26 wk 52 wk
Baseline characteristics
Patient characteristics (age, sex, education, race, ethnicity, marital status, income, work
status, number of pain sites)
x
Back pain (pain duration, interference with activities, days of pain in previous 6 months,
previous spinal injections, whether pain radiates into leg below knee)
x
Expectations for back pain improvement in general and as result of MBSR or CBT x
Primary outcomes
Back pain-related activity limitations in past week (modified RDQ) x x x x x
Bothersomeness of back pain in past week (0 to 10 scale) x x x x x
Secondary outcomes
Characteristic pain intensity (GCPS) (average of pain now, worst pain, average pain) x x x x
Depression (PHQ-8) x x x x
Anxiety (GAD-2) x x x x
Medications used for back pain in past week x x x x
Exercise in past week (back pain–specific and general) x x x x
Global improvement (PGIC) x x x
Program’s impact on thoughts, feelings, reactions, activities (open-ended) x x x
Potential mediators
MBSR: mindfulness (FFMQ-SF), pain acceptance (CPAQ-8) x x x x x
CBT: pain beliefs and appraisals (PSEQ; SOPA 2-item control, disability and harm scales;
PCS), pain coping strategies (CPCI activity pacing scale and 2-item relaxation scale)
x x x x x
Cost-effectiveness outcomes
Quality of life (EQ-5D, SF-6D from the SF-12) x x x x x
Out-of-plan visits paid for by patients since previous follow-up interview x x x x
Absenteeism, presenteeism (WPAI-CLBP) x x x x
Costs paid by GHC (payer) for back-related utilization of services (visits, tests, prescriptions)
and total costs (GHC members only) (from GHC electronic medical records for year prior
to trial and for follow-up year)
Intervention-related information
Class attendance (class records)
Adverse experiences from classes or home practice x x x x
New serious health problems since entering study x x x x
Self-reported home practice x x x x
Perceived helpfulness of classes and home practice x x x
Would recommend program to friends x x x
aCBT, Cognitive-behavioral therapy; CPAQ-8, 8-item Chronic Pain Acceptance Questionnaire; CPCI, Chronic Pain Coping Inventory; EQ-5D, European Quality of Life
(EuroQol) instrument in 5 dimensions; FFMQ, Five Facet Mindfulness Questionnaire; GAD-2, 2-item Generalized Anxiety Disorder scale; GCPS, Graded Chronic Pain
Scale; MBSR, Mindfulness-based stress reduction; PCS, Pain Catastrophizing Scale; PGIC, Patient Global Impression of Change scale; PHQ-8,8 item Patient Health
Questionnaire; PSEQ, Patient Self-efficacy Questionnaire; RDQ, Roland Disability Questionnaire; SF-6D, Short Form Health Survey in 6 dimensions; SF-12, 12-item
Short Form Health Survey; SOPA, Survey of Pain Attitudes; WPAI-CLBP, Work Productivity and Activity Impairment Questionnaire–Chronic Low Back Pain.
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be assessed using three items from the Graded Chronic
Pain Scale (GCPS). The GCPS has been validated and
shown to have good psychometric properties in a large
population survey and in large samples of primary care
patients with pain [63,64]. Participants will be asked to
rate the following three items on a 0 to 10 scale: their
current back pain (back pain “right now”), their worstback pain in the previous month and their average pain
level over the previous month.
Global improvement with treatment will be measured
with the Patient Global Impression of Change scale [65].
This single question asks participants to rate their im-
provement with treatment on a 7-point scale that ranges
from “very much improved” to “very much worse,” with
“no change” used as the midpoint. Global ratings of
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clinical benefit from treatment and are considered one of
the core outcome domains in pain clinical trials [49].
Use of medications and exercise for back pain during
the previous week will be assessed with the 8-, 26- and
52-week questionnaires.
General health status will be assessed with the 12-item
Short Form Health Survey (SF-12) [66], a widely used in-
strument that yields summary scores for physical and men-
tal health status. The SF-12 will also be used to calculate
quality-adjusted life-years (QALYs) using the Short Form
Health Survey in 6 dimensions in the cost-effectiveness
analyses [67].
Qualitative outcomes will be measured with open-
ended questions. We have included open-ended ques-
tions in our previous trials and found that they yield
valuable insights into participants’ feelings about the
value of specific components of the interventions and
the impact of the interventions on their lives. We there-
fore will include open-ended questions about these is-
sues at the end of the 8-, 26- and 52-week follow-up
interviews.Measures used in mediator analyses
In the MBSR arm, we will evaluate the mediating effects
of increased mindfulness (measured with the Nonreactiv-
ity, Observing, Acting with Awareness, and Nonjudging
subscales of the Five Facet Mindfulness Questionnaire
short form [68-70]) and increased pain acceptance (mea-
sured with the Chronic Pain Acceptance Questionnaire
[71,72]) on the primary outcomes. In the CBTarm, we will
evaluate the mediating effects of improvements in pain
beliefs and/or appraisals (measured with the Patient Self-
Efficacy Questionnaire [73]; the Survey of Pain Attitudes
2-item Control, Disability, and Harm scales [74-76]; and
the Pain Catastrophizing Scale [77-80]) and changes in
the use of pain coping strategies (measured with the
Chronic Pain Coping Inventory 2-item Relaxation scale
and the complete Activity Pacing scale [81,82]) on the pri-
mary outcomes. Although we expect the effects of MBSR
and CBT on outcomes to be mediated by different vari-
ables, we will explore the effects of all potential mediators
on outcomes in both treatment groups.Measures used in the cost-effectiveness analyses
Direct costs will be estimated using cost data extracted
from the electronic medical records for back-related ser-
vices provided or paid by GHC and from patient reports
of care not covered by GHC. Indirect costs will be
estimated using the Work Productivity and Activity Im-
pairment questionnaire [83]. The effectiveness of the
intervention will be derived from the SF-12 general health
status measure [84].Data collection, quality control and confidentiality
Data will be collected from participants by trained tele-
phone interviewers using a computer-assisted telephone
interview (CATI) version of the questionnaires to minimize
errors and missing data. Questions about experiences with
specific aspects of the interventions (for example, yoga,
meditation, instruction in coping strategies) that would
unmask interviewers to treatment groups will be asked at
each time point after all other outcomes have been
assessed. We will attempt to obtain outcome data from all
participants in the trial, including those who never attend
or drop out of the classes, those who discontinue enroll-
ment in the health plan and those who move away. Partici-
pants who do not respond to repeated attempts to obtain
follow-up data by telephone will be mailed a questionnaire
including only the two primary outcome measures and of-
fered $10 for responding.
We are will collect information at every stage of re-
cruitment, randomization and treatment so that we can
report patient flow according to the CONSORT (Con-
solidated Standards of Reporting Trials) guidelines [85].
To maintain the confidentiality of patient-related informa-
tion in the database, unique participant study numbers
will be used to identify patient outcomes and treatment
data. Study procedures are in place to ensure that all
masked personnel will remain masked to treatment group.
Protection of human participants and assessment of
safety
Protection of human participants
The GHC Institutional Review Board (IRB) approved
this study.
Safety monitoring
This trial will be monitored for safety by an independent
Data and Safety Monitoring Board (DSMB) composed of
a primary care physician experienced in mindfulness, a
biostatistician and a clinical psychologist with experience
in treating patients with chronic pain.
Adverse experiences
We will collect data on adverse experiences (AEs) from
several sources: (1) reports from the CBT and MBSR in-
structors of any participants’ experiences of concern to
them; (2) the 8-, 26- and 52-week CATI follow-up inter-
views in which the participants are asked about any
harm they felt during the CBT or MBSR treatment and
any serious health problems they had had during the re-
spective time periods; and (3) spontaneous reports from
participants. The project coinvestigators and a GHC pri-
mary care internist will review AE reports from all sources
weekly. Any serious AEs will be reported promptly to the
GHC IRB and the DSMB. AEs that are not serious will be
recorded and included in regular DSMB reports. Any
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DSMB chair within 7 days of discovery, regardless of
attribution.
Stopping rules
The trial will be stopped only if the DSMB believes that
there is an unacceptable risk of serious AEs in one or
more of the treatment arms. In this case, the DSMB can
decide to terminate one of the arms of the trial or the
entire trial.
Statistical issues
Sample size and detectable differences
Our sample size was chosen to ensure adequate power
to detect a statistically significant difference between each
of the two mind–body treatment groups and the usual
care group, as well as power to detect a statistically signifi-
cant difference between the two mind–body treatment
groups. Because we considered patient activity limitations
to be the more consequential of our two co–primary out-
come measures, we based our sample size calculations on
the modified RDQ [30]. We specified our sample size on
the basis of the expected percentage of patients with a
clinically meaningful improvement measured with the
RDQ at the 26-week assessment (that is, at least 30%
relative to baseline) [57].
Because of multiple comparisons, we will use Fisher’s
protected least significant difference test [86], first ana-
lyzing if there is any significant difference among all
three groups (using the omnibus χ2 likelihood ratio test)
for each outcome and each time point. If we find a dif-
ference, we will then test for pairwise differences be-
tween groups. We will need 264 participants (88 in each
group) to achieve 90% power to find either mind–body
treatment different from usual care on the RDQ. This as-
sumes that 30% of the usual care group and 55% of each
mind–body treatment group will have clinically meaning-
ful improvement on the RDQ at 26 weeks, rates of im-
provement that are similar to those we observed in a
similar back pain population in an evaluation of comple-
mentary and alternative treatments for back pain [87]. We
will have at least 80% power to detect a significant differ-
ence between MBSR and CBT on the RDQ if MBSR is at
least 20 percentage points more effective than CBT (that
is, 75% of the MBSR group versus 55% of the CBT group).
Our other co–primary outcome is the pain bother-
someness rating. With a total sample size of 264 partici-
pants, we will have 80% power to detect a difference
between a mind–body treatment group and usual care
on the bothersomeness rating scale, assuming that 47.5%
of usual care and 69.3% of each mind–body treatment
group have 30% or more improvement from baseline on
the pain bothersomeness rating scale. We will have at least
80% power to detect a significant difference betweenMBSR and CBT on the bothersomeness rating scale if
MBSR is at least 16.7 percentage points more effective
than CBT (that is, 87% of the MBSR group versus 69.3%
of the CBT group).
When analyzing the primary outcomes as continuous
measures, we will have 90% power to detect a 2.4-point
difference between usual care and either mind–body
treatment on the modified RDQ scale scores and a 1.1-
point difference between usual care and either mind–
body treatment on the pain bothersomeness rating scale
(assumes normal approximation to compare two inde-
pendent means with equal variances and a two-sided
P = 0.05 significance level with standard deviations of
5.2 and 2.4 for RDQ and pain bothersomeness measures,
respectively [88]. Assuming an 11% loss to follow-up
(slightly higher than that found in our previous back pain
trials), we plan to recruit a sample of 297 participants (99
per group).
Both of the co–primary outcomes will be tested at the
P < 0.05 level at each time point because they address
separate scientific questions. Analyses of both outcomes
at all follow-up time points will be reported, imposing a




In our comparisons of treatments based on the outcome
measures, we will analyze outcomes assessed at all follow-
up time points in a single model, adjusting for possible
correlation within individuals and treatment group co-
horts using generalized estimating equations [89]. Because
we cannot reasonably make an assumption regarding con-
stant or linear group differences over time, we will include
an interaction term between treatment groups and time
points. We plan to adjust for baseline outcome values, sex
and age, as well as other baseline characteristics found
to differ significantly by treatment group or follow-up
outcomes, to improve precision and power of our statis-
tical tests. We will conduct the following set of analyses
for both the continuous outcome score and the binary
outcome (clinically significant change from baseline),
including all follow-up time points (4, 8, 26 and
52 weeks). The MBSR treatment will be deemed suc-
cessful only if the 26-week time point comparisons are
significant. The other time points will be considered
secondary evaluations.
We will use an intent-to-treat approach in all analyses;
that is, the assessment of individuals will be analyzed by
randomized group, regardless of participation in any
classes. This analysis minimizes biases that often occur
when participants who do not receive the assigned treat-
ments are excluded from analysis. The regression model
will be in the following general form:
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þ α3 treatmentð Þ  timeþ α4z þ ε;
where yt is the response at follow-up time t, baseline is
the prerandomization value of the outcome measure,
treatment includes dummy variables for the MBSR and
CBT groups, time is a series of dummy variables indicat-
ing the follow-up times and z is a vector of covariates
representing other variables adjusted for. (Note that α1,
α2, α3 and α4 are vectors.) The referent group in this
model is the usual care group. For binary and continu-
ous outcomes, we will use appropriate link functions
(for example, logit for binary). For each follow-up time
point at which the omnibus χ2 test is statistically signifi-
cant, we will go on to test whether there is a difference
between MBSR and usual care to address aim 1 and a
difference between MBSR and CBT to address aim 2.
We will also report the comparison of CBT to usual care.
When determining whether MBSR is an effective treat-
ment for back pain, we will require that aim 1, the com-
parison of MBSR to usual care, must be observed.
On the basis of our previous back pain trials, we ex-
pect at least an 89% follow-up and, if that holds true,
our primary analysis will be a complete case analysis, in-
cluding all observed follow-up outcomes. However, we
will adjust for all baseline covariates that are predictive
of outcome, their probability of being missing and differ-
ences between treatment groups. By adjusting for these
baseline covariates, we assume that the missing outcome
data in our model are missing at random (given that
baseline data are predictive of missing data patterns) in-
stead of missing completely at random. We will also
conduct sensitivity analysis using an imputation method
for nonignorable nonresponses to evaluate whether our
results are robust enough to compensate for different
missing data assumptions [90].
Mediator analyses If MBSR or CBT is found to be ef-
fective (relative to usual care and/or to each other) in
improving either primary outcome at 26 or 52 weeks, we
will move to aim 3 to identify the mediators of the ef-
fects of MBSR and group CBT on the RDQ and pain
bothersomeness scale. We will perform the series of me-
diation analyses separately for the two primary outcomes
(RDQ and pain bothersomeness scale scores) and for
each separate treatment comparator of interest (usual
care versus CBT, usual care versus MBSR and CBT ver-
sus MBSR). We will conduct separate mediator analyses
for the 26- and 52-week outcomes (if MBSR or CBT is
found to be effective at those time points).
Next, we describe in detail the mediator analysis for
the 26-week time point. A similar analysis will be con-
ducted for the 52-week time point. We will apply the
framework of the widely used approach of Baron andKenny [91]. Once we have demonstrated the association
between the treatment and the outcome variable (the
“total effect” of the treatment on the outcome), the sec-
ond step will be to demonstrate the association between
the treatment and each putative mediator. We will con-
struct a regression model for each mediator with the 4- or
8-week score of the mediator as the dependent variable
and the baseline score of the mediator and treatment indi-
cator as independent variables. We will conduct this ana-
lysis for each potential mediator and will include as
potential mediators in the following step only those that
have a P-value ≤0.10 for the relationship with the treat-
ment. The third step will be to demonstrate the reduction
of the treatment effect on the outcome after removing the
effect of the mediators. We will construct a multimediator
inverse probability weighted (IPW) regression model [92].
This approach will allow us to estimate the direct effects
of treatment after rebalancing the treatment groups with
respect to the mediators. Specifically, we will first model
the probability of the treatment effects, given the media-
tors (that is, all mediators that were found to be associated
with treatment in step 2), using logistic regression and
adjusting for potential baseline confounders. Using this
model, we will obtain the estimated probability that each
person received the observed treatment, given the ob-
served mediator value. We will then use an IPW regres-
sion analysis to model the primary outcomes on treatment
status while adjusting for the baseline levels of the out-
come and mediator. Comparing the weighted model with
the unweighted model will allow us to estimate how much
of the direct effect of treatment on the associated outcome
can be explained by each potential mediator. The inclu-
sion in step 3 of all mediators found to be significant in
step 2 will enable us to examine whether the specific vari-
ables that we hypothesized would differentially mediate
the effects of MBSR versus CBT in fact mediate the effects
of each treatment independently of the effects of the other
“process variables”.
Cost-effectiveness analyses
A societal perspective cost–utility analysis (CUA) will be
performed to compare the incremental societal costs re-
vealed for each treatment arm (direct medical costs paid
by GHC and the participant plus productivity costs) to
incremental effectiveness in terms of change in partici-
pants’ QALYs [93]. This analysis will be possible only for
study participants recruited from GHC. This CUA can
be used by policymakers concerned with the broad allo-
cation of health-related resources [94,95]. For the payer
perspective, direct medical costs (including intervention
costs) will be compared to changes in QALYs. This CUA
will help us to determine whether it makes economic
sense for MBSR to be a reimbursed service among this
population. A bootstrap methodology will be used to
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conducted to assess the sensitivity of the results to differ-
ent cost outcome definitions, such as varying assumptions
of wage rates used to value productivity and the inclusion
of non-back-related health-care resource utilization [97]
in the total cost amounts, will also be considered. In cost-
effectiveness analyses, we will use intention to treat and
adjust for health-care utilization costs in the one calendar
year prior to enrollment and for baseline variables that
might be associated with treatment group or outcome,
such as medication use, to control for potential con-
founders. We expect there will be minimal missing data,
but sensitivity analyses (as described above for the primary
outcomes) will also be performed to assess cost measures.
Discussion
In this trial, we will seek to determine whether an in-
creasingly popular approach for dealing with stress—
mindfulness-based stress reduction—is an effective and
cost-effective treatment option for persons with chronic
back pain. Because of its focus on the mind as well as
the body, MBSR has the potential to address some of
the psychosocial factors that are important predictors of
poor outcomes. In this trial, we will compare the effect-
iveness and cost-effectiveness of MBSR with that of
CBT, which has been found to be effective for back pain
but is not widely available. The study will also explore
psychosocial variables that may mediate the effects of
MBSR and CBT on patient outcomes. If MBSR is found
to be an effective and cost-effective treatment option for
persons with chronic back pain, it will be a valuable
addition to the treatment options available for patients
with significant psychosocial contributors to this problem.
Trial status
Recruitment started in August 2012 and was completed
in April 2014.
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